首页> 外文期刊>International journal of obstetric anesthesia >Remifentanil patient-controlled intravenous analgesia during labour: a retrospective observational study of 10 years' experience
【24h】

Remifentanil patient-controlled intravenous analgesia during labour: a retrospective observational study of 10 years' experience

机译:劳动力期间副丹丁尼尔患者控制的静脉内镇痛:回顾性的10年经验研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Intravenous remifentanil patient-controlled analgesia (PCA) has been routinely available for labouring women in our unit since 2004, the regimen using a 40 jig bolus available two minutely on demand, continuous pulse oximetry and mandatory one-to-one care. We examined remifentanil use and compared, with the other analgesic options available in our unit, outcomes such as mode of delivery, Apgar scores, neonatal resuscitation and admission to the neonatal intensive care unit. Methods: We retrospectively identified women who delivered in our unit between 2005 and 2014 and received remifentanil, diamorphine or epidural analgesia during labour. Data were drawn from the Northern Ireland Maternity System electronic database, which records birth details from all obstetric units in Northern Ireland. Additional data were identified from paper survey forms, completed by the midwife post delivery for all women who received remifentanil in our unit. Outcomes were compared between women who received remifentanil, diamorphine or an epidural technique for labour analgesia. Results: Over the 10-year period, remifentanil was the most popular form of analgesia, being selected by 31.9% (8170/25617) women. Compared with women selecting diamorphine or epidural analgesia, those having remifentanil had similar rates of instrumental and operative delivery. Neonatal Apgar scores were also similar. Neonatal resuscitation or neonatal unit admission were not more likely in women choosing remifentanil PCA. Conclusion: We found remifentanil PCA to be neither less safe nor associated with poorer outcomes than other analgesic options offered in our unit, when used within our guidelines for more than a 10-year period.
机译:背景技术:自2004年以来,静脉内雷芬尼患者控制镇痛(PCA)经常可用于我们单位的劳动妇女,该方案使用40夹jig推注的方案,每次按需,连续脉冲血液血液和强制性一体化。我们检查了副芬太尼尔使用并进行了比较,在我们的单位中提供的其他镇痛选项,交付模式,APGAR评分,新生儿复苏和入场等结果等结果。方法:我们回顾性地确定了2005年至2014年之间交付的妇女,并在劳动期间接受了副芬丹内尼尼尔,氨基甲胺或硬膜外镇痛。数据来自北爱尔兰产科系统电子数据库,该数据库记录了来自北爱尔兰所有产科单位的出生细节。额外的数据是从纸张调查表格中确定的,由助产士拨款完成,为我们单位的所有妇女接受副遗传岛的所有妇女完成。在接受副芬丹内尼尼尔,二殖民或劳动镇痛的硬膜外技术之间的妇女之间比较结果。结果:在10年期间,雷芬坦尼是最受欢迎的镇痛形式,被31.9%(8170/25617)选为妇女。与选择硅啡或硬膜外镇痛的女性相比,那些雷丁坦的人具有类似的仪器和手术递送。新生儿APGAR评分也相似。新生儿复苏或新生儿单位入院并不更有可能在选择雷芬丹林PCA的女性中。结论:我们发现雷芬坦尼尔PCA既不是不那么安全,也不与我们单位提供的其他镇痛选项相比,我们在我们的指导方针中使用了超过10年的时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号